Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Lantheus Holdings Is Dropping Today


Shares of Lantheus Holdings (NASDAQ: LNTH), a company focused on diagnostic medical imaging equipment and supplies, dropped 21% as of 10:35 a.m. EDT on Wednesday after the company announced that it is acquiring Progenics Pharmaceuticals (NASDAQ: PGNX), a commercial-stage biotechnology company focused on cancer.

Here are the key terms of the deal:

Traders don't appear to share management's enthusiasm for the deal and are responding accordingly.

Continue reading


Source Fool.com

Like: 0
Share

Comments